ACIP Live Meeting Archive – June 21-23, 2023

Meeting Agenda June 21-23, 2023 [PDF – 174 KB]

You tube icon


Video of ACIP meetings is now posted to the CDC Streaming Health channel* on YouTube. View the specific ACIP channel on YouTube or view specific links below. Controls for video volume, pause, and rewind appear along the bottom of the display.

Videos: June 21, 2023

Welcome & RSV Vaccines – Adult [275 minutes]
Introduction; Manufacturer presentation: Pfizer season 2 safety & efficacy; coadministration with influenza vaccine, Manufacturer presentation: GSK season 2 safety & efficacy; coadministration with influenza vaccine, Updated cost-effectiveness of the Pfizer and GSK vaccines (main CDC model), Comparison of cost effectiveness results of the main CDC model and each manufacturer model (Pfizer & GSK), Updated EtR (incl. GRADE) and clinical considerations for 2 vaccines (Pfizer & GSK)

Polio Vaccine [47 minutes]
Introduction; Recommendations for Adult Polio Vaccination

Influenza Vaccines [84 minutes]
Introduction; WG considerations; Proposed Recommendations  

Public Comment & Votes [46 minutes]
Public Comment  & Votes

Videos: June 22, 2023

Welcome, Pneumococcal Vaccines [156 minutes]
Introduction; Economic analysis and public health impact of PCV20 use in children; Comparison of cost-effectiveness analyses on PCV20 use in children; Summary of WG interpretation on EtR and policy options

Dengue Vaccines [78 minutes]
Introduction; Introduction of policy questions for TAK-003; Cost effectiveness analysis and health impacts of routine vaccination with TAK-003 dengue vaccine in Puerto Rico; Summary of two economic models for dengue vaccine TAK-003 use in Puerto Rico; Partial EtR framework for TAK-003

Chikungunya Vaccine [51 minutes]
Introduction; Value of chikungunya vaccine to U.S. travelers and providers; Chikungunya virus infection among laboratory workers; Update on large chikungunya outbreak in Paraguay; Workgroup plans and timelines

Respiratory Syncytial Virus Vaccines – Pediatric/Maternal [170 minutes]
Introduction; Economic analysis of RSVpreF in pediatric populations; EtR Pfizer maternal RSV vaccine; Economic analysis of combined use of nirsevimab and maternal RSVpreF vaccine; Clinical considerations for RSV maternal vaccine and nirsevimab

Public Comment & Votes [34 minutes]
Public Comment  & Votes

Videos: June 23, 2023

Welcome, Mpox Vaccine [124 minutes]
Introduction; Updates From the 2022/2023 U.S. Mpox Outbreak: Epidemiology, Vaccine Safety, and Vaccine Effectiveness; Use of JYNNEOS During Mpox Outbreaks: Clinical guidance ; Considerations for Long-term Protection Against Mpox

Meningococcal Vaccines [91 minutes]
Introduction; Cost effectiveness analysis; GRADE/EtR; Summary and workgroup considerations

Vaccine Safety [58 minutes]
Introduction; The childhood immunization schedule and safety: Studies in the Vaccine Safety Datalink; Preliminary evaluation of aluminum content in childhood vaccines and risk of asthma in a Danish nationwide cohort

COVID-19 Vaccines [104 minutes]
Introduction; Updates to COVID-19 epidemiology and vaccine effectiveness; Infection-induced and hybrid immunity; Summary and work group considerations


*The CDC Streaming Health channel on YouTube hosts more than 600 videos on a variety of health topics. YouTube’s design allows viewing on mobile devices, tablets, desktops, and laptops.

Top of Page